COVID vaccination site closes after adverse J&J vax reactions

Image: Logos World

Thirteen people at a COVID-19 vaccination site in Colorado had adverse reactions to the Johnson & Johnson vaccine on Wednesday — shutting down operations for the day, a report said.

Officials did not disclose the types of reactions suffered by less than 1 percent of the more than 1,700 people given shots at Dick’s Sporting Goods Park in Commerce City, the Denver Gazette reported.

The vaccination effort was being sponsored by the state and Centura Health. More than 600 people with appointments Wednesday were unable to receive their vaccinations after the early closure.

We followed our protocols and in an abundance of caution, made the decision — in partnership with the state — to pause operations for the remainder of the day,” Centura Health officials said in the statement obtained by the newspaper.

People with appointments who were turned away will be rescheduled to receive their shots at a different site on Sunday.

Officials did not disclose the types of reactions suffered by less than 1 percent of the more than 1,700 people given shots.

See more here: ampproject.org

Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Comments (3)

  • Avatar

    very old white guy

    |

    Just a slight hiccup. We will poison them at another site.

    Reply

  • Avatar

    Alan

    |

    The efficacy of the vaccines is less than 1% so now we have the evidence that the risk of side-effects is about the same.

    Reply

  • Avatar

    Cris

    |

    I do not understand why this company that has such as terrible reputation in the pharmaceutical world and whose products killed and injured so many is allowed to operate at all especially during a state of emergency.

    Reply

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via